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tophagy in vivo, is clearly associated with the increased bac-
terial infection and the onset of colitis. Interestingly, the phe-
notype of aberrant Paneth cells and dextran sodium sul-
phate-induced colitis in ATG16L1 hypomorphic mice closely 
resembles human CD. Taken together, the available data 
strongly suggest an important role for autophagy in main-
taining intestinal homeostasis, and dysfunction of autopha-
gy seems to be a major risk factor for the onset of chronic 
intestinal inflammation.  Copyright © 2012 S. Karger AG, Basel 
 Genetic, immunological and bacterial factors are be-
lieved to contribute essentially to the pathogenesis of in-
flammatory bowel disease (IBD). According to a current 
hypothesis, an epithelial barrier defect, coupled with a 
dysfunctional immune response of the innate as well as 
the acquired immune system to commensal flora, results 
in either excessive upregulation or impaired downregula-
tion of inflammatory events, finally precipitating the de-
velopment of chronic intestinal inflammation  [1] . Recent 
data demonstrated that the intestinal flora is significant-
ly altered in IBD, since mucosal microbial diversity is re-
duced, particularly in Crohn’s disease (CD). Species com-
position is also disturbed, since the number of Firmicutes 
is reduced in the intestinal tract of IBD patients while 
concurrent increases in Bacteroidetes – and in CD only, 
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 Abstract 
 Recent genome-wide association studies identified single 
nucleotide polymorphisms within gene loci, encoding
autophagy genes, e.g. the autophagy-related 16-like 1
(ATG16L1) and the immunity-related GTPase family M (IRGM), 
as an important risk factor for the onset of chronic inflamma-
tory diseases such as Crohn’s disease (CD) or rheumatoid ar-
thritis. CD is characterized by a breakdown of the intestinal 
epithelial barrier function leading to an overwhelming and 
uncontrolled immune response to bacterial antigens. Au-
tophagy, and therefore ATG16L1 and IRGM, are critically in-
volved in the innate immune response to invading patho-
gens. Dysfunction of these molecules results in the increased 
survival of intracellular bacteria, defective antigen presenta-
tion and proinflammatory cytokine secretion. Interestingly, 
autophagy can also be regulated by other CD susceptibility 
genes, such as nucleotide oligomerization domain 2 or pro-
tein tyrosine phosphatase nonreceptor type 2, and the pres-
ence of the CD-associated variations within these genes re-
sults in comparable effects. ATG16L1 also plays a crucial role 
in maintaining Paneth cell function and morphology, while 
IRGM seems to be associated with mitochondrial function 
and apoptosis. Dysfunction of these molecules, i.e. of au-
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 Enterobacteriaceae  – can be detected  [2] . Genome-wide 
association studies identified replicated variations in 99 
gene loci to be associated with IBD  [3] . While 28 of these 
gene loci are associated with the onset of both CD and 
ulcerative colitis (UC), a large number are attributed spe-
cifically to the development of either one or the other. As 
an example, innate immune system genes, such as the in-
tracellular bacterial-sensor nucleotide oligomerization 
domain 2 (NOD2), the autophagy genes autophagy 16-
like 1 (ATG16L1) and the immunity-related GTPase fam-
ily, M (IRGM)  [3] , are exclusively associated with CD.
 Autophagy 
 Besides its genetic association with CD, dysfunction of 
autophagy has been implicated in numerous pathologies, 
such as cancer or neurodegeneration  [4] . One of the fun-
damental roles of autophagy in maintaining cellular ho-
meostasis comprises generating energy and degrading 
cytoplasmic compartments, damaged organelles and 
misfolded proteins. In autophagosomes, these structures 
are sequestered into double-membrane-enclosed vesicles 
and are delivered to lysosomes for final degradation  [4–
6] . Autophagy is also critically involved in the regulation 
of innate immune responses by providing a first-line de-
fense against intracellular pathogens, such as  Listeria 
monocytogenes or  Salmonella typhimurium , recognizing 
intracellular viruses and mediating antigen presentation 
via major histocompatibility complex class II molecules 
 [7–9] . Consequently, dysfunctional autophagy is associ-
ated with defective bacterial handling, the prolonged in-
tracellular survival of pathogens and uncontrolled in-
flammation. Of particular interest, levels of autophagy 
proteins, like ATG16L1, IRGM or LC3B-II, are signifi-
cantly decreased in the intestinal tissue of CD patients 
when compared to non-IBD control patients ( fig. 1 a)  [10] .
 Autophagy occurs either as macroautophagy, microau-
tophagy or chaperone-mediated autophagy. The activa-
tion of macroautophagy occurs during cellular stress, e.g. 
during starvation or hypoxia, as well as in response to an-
tigens or pathogens. A critical regulator of autophago-
some formation is the molecular target of rapamycine 
(mTOR)  [11] . Hereby, activated mTOR acts as an inhibitor 
of autophagy. In addition, the prolonged activation of au-
tophagy finally results in the activation of mTOR as part 
of a negative feedback mechanism  [12] . Following the in-
hibition of mTOR, the formation of autophagosomes is 
mediated by two highly conserved protein conjugation 
systems. After activation of beclin-1, autophagosome as-
sembly involves ATG12-ATG5 conjugation which is cata-
lyzed by ATG7 and ATG10. The resulting ATG5-ATG12 
conjugate is stabilized by a noncovalent complex with
ATG16L1. This complex mediates, in addition to ATG7 
and ATG3, the conversion of LC3B-I to LC3B-II by lipida-
tion with phosphatidylethanolamine, which finally estab-
lishes the formation of functional autophagosomes. These 
structures colocalize with lysosomes to finally degrade 
their content into the so-called autophagolysosomes  [13] .
 Autophagy Genes as Risk Factors for CD 
 To date, three genes associated with autophagy in hu-
mans have been confirmed as CD susceptibility genes, 
namely ATG16L1, IRGM and leucine-rich repeat kinase 
2 (LRRK2)  [3] . A fourth one, namely unc-51-like kinase 
1 (ULK1) has only been associated with autophagy in a 
specific study of single-nucleotide polymorphisms (SNPs) 
in autophagy-related genes. Though ULK1 is important 
for the formation of autophagosomes by forming a com-
plex with ATG1, the functional relevance of the CD-as-
sociated SNPs within the ULK1 gene locus is unknown 
 [14] . Of note, none of the four genes has been associated 
with an increased risk of developing UC.
 ATG16L1, responsible for subcellular localization of 
the autophagy machinery, represents a key molecule with-
in the autophagy network  [15] . The SNP rs2241880 within 
the gene encoding ATG16L1 causes a switch from the A to 
the G allele at position 300. The presence of the disease-
associated genotype GG results in the substitution of thre-
onine by alanine (T300A). The T300A variation is present 
in 58.1 % of CD patients (vs. 51.3% of non-IBD control 
patients) and has been strongly associated with an in-
creased risk of developing CD (particularly ileal CD), but 
not UC  [16–18] . It is well described that ATG16L1 protein 
is involved in the formation of functional autophago-
somes, but recent evidence has emerged that it also plays 
a crucial role in maintaining and regulating other cell 
functions, such as the secretion of cytokines as well as 
morphology and protein expression in Paneth cells. Of 
note, ATG16L1 knock-out mice die on the first day of life 
because they are not able to withstand postnatal starva-
tion  [19] .
 A synonymous variation within the coding region of 
IRGM (rs10065172, c.313C 1 T) has been strongly associ-
ated with CD  [17] . A further study revealed that this poly-
morphism exists in perfect linkage disequilibrium with a 
20-kb deletion polymorphism upstream of the IRGM 
transcriptional start site. Interestingly, this deletion affects 
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several transcription-factor-binding sites and thereby 
strongly impairs IRGM expression levels in a cell-specific 
manner  [20] . In addition, a number of polymorphisms 
within the promoter region or the 5  untranslated region 
of IRGM are independently associated with CD  [21] . Re-
duced expression of IRGM seems to be responsible for the 
decrease in its function and a subsequent impairment in 
autophagy, suggesting that a certain level of IRGM protein 
is necessary for proper protein function. Obviously, this 
level cannot be reached in cells carrying the CD-associat-
ed IRGM variants. The most important function of IRGM 
seems to be to protect the cells from invading bacteria. In 
contrast to ATG16L1-deficient mice, IRGM-deficient mice 
are vital, but less resistant to invading bacteria  [22] .
 Recently, LRRK2, which plays a pivotal role in regulat-
ing autophagic activity, has been confirmed in CD sus-
ceptibility  [23] . Only one of the CD-associated SNPs is 
located within the coding region of LRRK2, namely 
rs376186, which results in a decreased stability of the pro-
tein product leading to lower expression levels in Met2397 
carriers  [24] . LRRK2-deficient mice are more susceptible 
to dextran sodium sulphate (DSS)-induced colitis, since 
LRRK2 inhibits the activation of NFAT1 which promotes 
the secretion of proinflammatory cytokines  [25] . LRRK2 
expression is elevated in the intestinal tissue of CD pa-
tients and LRRK2-deficient cells are impaired in their 
ability to kill intracellular bacteria  [26] , suggesting a pos-
sible role for LRRK2 in CD pathogenesis.
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 Fig. 1. Autophagy is altered in CD patients. 
 a Protein levels of ATG16L1 and IRGM are 
decreased in colonic biopsies derived from 
CD patients when compared to non-IBD 
controls (Con).  b Loss of PTPN2 results in 
decreased formation of LC3B-positive au-
tophagosomes, but increased levels of in-
tracellular  L. monocytogenes .  c In primary 
colonic lamina propria fibroblasts from 
CD patients, the presence of the CD-asso-
ciated PTPN2 variation impairs autopha-
gosome formation and favors the onset of 
intracellular  L. monocytogenes . WT = 
Wild-type. Reprodued from [10]. 
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 Autophagy and Bacterial Handling 
 Recent studies demonstrate that the presence of the 
CD-associated ATG16L1 variant results in increased 
numbers as well as in prolonged survival and elevated 
replication of intracellular  Salmonella  spp.,  Escherichia 
coli  spp.  or  Shigella flexneri .  In particular,  adherent-inva-
sive E. coli  (AIEC) are well associated with (ileal) CD and 
are known to colonize ileal CD lesions. ATG16L1 variant 
cells are not sufficient to limit the replication of AIEC, 
while their effectiveness against other  E. coli strands is 
not impaired  [27] . Further studies revealed that enhanced 
intracellular survival and replication of AIEC in
ATG16L1 (and IRGM or NOD2) mutant cells featuring 
dysfunctional autophagy also result in elevated secretion 
of the proinflammatory cytokines TNF and IL-6 finally 
promoting inflammatory conditions in the intestine  [28] . 
Increased cytokine production in ATG16L1 mutant cells 
was also observed in a study using  Mycobacterium tuber-
culosis (MTB). Here, mononuclear cells carrying the 
T300A variation featured increased IFN  secretion when 
compared to ATG16L1 wild-type cells in response to 
MTB  [29] . Of note, the presence of the ATG16L1 variation 
obviously only affects the extent of autophagy following 
activation, while the basal levels of autophagy remain un-
affected when compared to ATG16L1 wild-type cells. 
However, T300A-variant carrying intestinal epithelial 
cells are clearly impaired in handling and capturing in-
vading  S. typhimurium  [30] . These observations strongly 
suggest a critical involvement of dysfunctional ATG16L1 
and consequently autophagy in the pathogenesis of CD.
 Comparable findings were obtained for IRGM. In 
mice, sufficient IRGM1 expression plays a crucial role in 
protecting the animals from pathogenic bacteria or pro-
tozoans. It has been shown that functional IRGM1 plays 
a key role in regulating the maturation of pathogen-con-
taining vacuoles as well as the adhesion and motility of 
activated macrophages. Consequently, IRGM1 deficiency 
results in increased susceptibility of the mice to patho-
gens, such as MTB,  L. monocytogenes ,  S. typhimurium or 
 Toxoplasma gondii and finally in systemic infections  [22, 
31, 32] . Singh et al.  [33]  could clearly demonstrate that 
IRGM is crucial for IFN  -mediated autophagy and for the 
elimination of intracellular  M. tuberculosis in human 
macrophages. Further studies demonstrated that siRNA-
induced knock-down of IRGM in human cells, resulting 
in a defect of the autophagy machinery, favors the persis-
tence of AIEC, resulting in increased proinflammatory 
responses  [27, 28] . As mentioned above, a certain thresh-
old level of IRGM expression seems to be necessary for 
proper molecule function. This observation has been con-
firmed by McCarroll et al. [20] , since the efficiency of the 
autophagy machinery against invading  S. typhimurium in 
human cells can be reduced by the siRNA-mediated 
knock-down of IRGM, but is enhanced by the overexpres-
sion of IRGM. Further confirmation comes from a study 
showing that an SNP that increases IRGM expression 
contributes to protection from MTB  [34] . The necessary 
threshold level can obviously not be reached in the pres-
ence of the CD-associated polymorphisms, and lower lev-
els of IRGM expression have been detected in lympho-
cytes from CD patients  [21] . Interestingly, a recent study 
demonstrated that the microRNA family, miR-196, which 
is overexpressed in the inflamed intestinal epithelium of 
CD patients, causes a downregulation of the protective 
IRGM variant, but does not affect levels of the disease-
associated variant. The resulting decrease in IRGM ex-
pression levels contributes to impaired autophagy and en-
hanced intracellular replication of AIEC  [35] . In addition, 
IRGM exerts a high affinity to mitochondrial cardiolipin, 
translocates to the mitochondria and induces either mito-
chondrial fission or depolarization. While IRGM-induced 
mitochondrial fission is necessary for controlling intra-
cellular mycobacteria, IRGM-induced mitochondrial de-
polarization is associated with autophagy-independent 
cell death, which suggests a role for IRGM not only in con-
trolling pathogen invasion but also in regulating damag-
ing inflammation as is observed in CD  [36] . Of note, the 
IRGM CD risk variant is associated with increased sero-
positivity for antiflagellin antibodies in CD patients  [37] .
 Autophagy and NOD2 
 Recent studies clearly demonstrated a close functional 
correlation between ATG16L1 and other IBD susceptibil-
ity genes, such as NOD2, in regulating autophagy. Similar 
to ATG16L1, NOD2 has been associated with a severe 
structuring and/or penetrating CD phenotype featuring 
ileal disease  [18, 38] . NOD2 serves as an intracellular re-
ceptor for the bacterial wall component, muramyl-dipep-
tide, and initiates cellular antibacterial responses by acti-
vating the innate immune system  [39] . Presence of the 
CD-associated NOD2 variants results in a dysregulated 
response of the intestinal epithelium to bacterial antigens 
leading to uncontrolled proinflammatory events in vitro 
and in vivo  [40, 41] . Muramyl-dipeptide seems to repre-
sent a powerful activator of autophagy via NOD2  [7, 8, 
42] . In dendritic cells, NOD2-mediated autophagy is cru-
cial for the handling of invading bacteria as well as for 
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antigen presentation and the induction of antigen-specif-
ic CD4+ T cell responses via major histocompatibility 
complex class II molecules. Interestingly, dendritic cells 
from CD patients carrying either the CD-associated
ATG16L1 or NOD2 variations are defective in autopha-
gosome formation, bacterial trafficking and antigen pre-
sentation  [8] . As a possible mechanism, Travassos et al. 
 [7]  showed that NOD2 is crucial for the initiation of au-
tophagy by recruiting ATG16L1 to the cell membrane at 
the site of bacterial entry. Cells featuring CD-associated 
NOD2 polymorphisms are unable to direct ATG16L1 to 
the plasma membrane and are deficient in their handling 
of invading  S. flexneri . The presence of the CD-associat-
ed ATG16L1 variant resulted in increased secretion of the 
proinflammatory cytokines IL-1  and IL-6 from periph-
eral blood mononuclear cells from CD patients in re-
sponse to stimulation with NOD2 ligands  [43] . These ob-
servations strongly suggest that NOD2 as well as autoph-
agy plays a key role in the innate immune system and 
present the functional mechanism of how autophagy dys-
function can essentially contribute to the onset of chron-
ic intestinal inflammation. Of note, the combined pres-
ence of CD-associated variations 3020insC within the 
NOD2 gene and T300A within the ATG16L1 gene is as-
sociated with the development of anti- Saccharomyces 
cerevisiae antibodies in CD patients  [37] .
 Autophagy and PTPN2 
 Recent studies also demonstrated a close functional 
correlation between the IBD susceptibility gene, protein 
tyrosine phosphatase nonreceptor type 2 (PTPN2),
ATG16L1, NOD2 and autophagy in general. PTPN2 has 
been well characterized as a key regulator of immune-re-
lated signalling pathways and functions  [44] . Its expres-
sion is, at least partially, regulated by ATG16L1 and NOD2 
 [10, 45] . On a functional level, PTPN2 seems to also be in-
volved in NOD2-mediated autophagy, because the pres-
ence of the CD-associated PTPN2 variations results in im-
paired autophagosome formation in human monocytes in 
response to muramyl-dipeptide  [45] . Dysfunction of 
PTPN2 is associated with decreased expression of autoph-
agy genes such as IRGM and ATG16L1. Interestingly, the 
presence of the CD-associated variations within the 
PTPN2 gene in primary colonic lamina propria fibro-
blasts from CD patients resulted in defective autophago-
some formation and an increased intracellular number of 
invading  L. monocytogenes ( fig. 1 b, c). Moreover, the loss 
of PTPN2 in intestinal epithelial cells resulted in elevated 
IEC apoptosis, which was dependent on defective autoph-
agy in these cells  [10] . All of these events have been well 
associated with the onset of IBD, confirming the role for 
dysfunctional autophagy in IBD pathogenesis.
 ATG16L1 and Paneth Cell Function 
 Besides its role in the handling of invading pathogens, 
ATG16L1 has been critically associated with the function 
of Paneth cells located within the crypts of Lieberkühn in 
the small intestine. Paneth cells represent a specialized 
epithelial cell type which is important for the secretion of 
antimicrobial factors into the intestinal lumen via the 
production and secretion of characteristic cytoplasmic 
granules. In ATG16L1, hypomorphic (ATG16L1 HM ) mice, 
Cadwell et al.  [46]  found severe abnormalities in Paneth 
cell morphology and in their granule exocytosis path-
ways. In particular, ATG16L1 HM mice lack the antibacte-
rial enzyme, lysozyme, in the mucus of ileal sections 
compared to wild-type mice. Additionally, lysozyme was 
diffusely detectable in a number of Paneth cells in
ATG16L1 HM mice accompanied by aberrant, disorga-
nized granules as well as decreased numbers of granules. 
Further characteristic features of ATG16L1 HM Paneth 
cells were degenerated mitochondria and the absence of 
apical microvilli. These abnormalities were in 100% con-
cordance with the ATG16L1 HM genotype, suggesting an 
impaired exocytosis pathway in Paneth cells featuring 
defective autophagy. However, resistance to  L. monocyto-
genes was not affected by the altered release of Paneth cell 
granules in these animals. Moreover, Paneth cells from 
ATG16L1 HM mice revealed a gain of function with re-
spect to the expression of molecules being involved in 
proinflammatory responses, such as peroxisome prolif-
erator-activate receptor (PPAR) signalling as well as the 
adipocytokines, leptin and adiponectin  [46] . Of special 
interest, Paneth cells derived from CD patients homozy-
gous for the ATG16L1 CD risk allele feature similar ab-
normalities in Paneth cell morphology and granule se-
cretion as ATG16L1 HM mice  [46] , strongly suggesting a 
key role for dysfunctional ATG16L1 and, subsequently, 
autophagy, in the pathogenesis of CD.
 Autophagy and Colitis 
 Interestingly, all of the mentioned abnormalities in 
Paneth cell morphology and function were absent when 
the ATG16L1 HM mice were raised in an enhanced barrier 
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facility, but could be introduced again completely follow-
ing the infection of the mice with the murine norovirus 
strain CR6 for 7 days, strongly suggesting a critical role 
for a virus-plus-susceptibility gene interaction  [47] . In-
fection with murine norovirus also caused a unique gene 
expression pattern in ATG16L1 HM Paneth cells, favoring 
the expression of genes being associated with intracellu-
lar protein traffic, targeting and localization as well as 
with amino acid metabolism  [47] . ATG16L1 HM mice only 
displayed a severe intestinal injury response to DSS treat-
ment when they were infected with murine norovirus 
CR6 at least 7 days before DSS administration, but not in 
the absence of the virus or when the virus infection oc-
curred when starting DSS treatment. Of note, the virus-
preinfected ATG16L1 HM mice featured multiple charac-
teristic human CD hallmarks, such as increased inflam-
mation in the muscularis, increased numbers of lymphoid 
aggregates, subserosal fibrosis, hypertrophy of the mus-
cularis propria, mucosal atrophy, ileal involvement and 
ulcerations  [47] . The extent of the inflammatory reaction 
was critically dependent on the presence of TNF, IFN  
and commensal bacteria, since treatment with anti-TNF 
antibodies, anti-IFN  antibodies and antibiotics resulted 
in a marked decrease in the inflammatory response  [47] . 
These observations strongly suggest that virus-plus-sus-
ceptibility gene interactions as well as environmental fac-
tors and commensal bacteria are critically involved in the 
pathogenesis of chronic intestinal inflammation. Fur-
thermore, there is also evidence for a functional connec-
tion between IRGM and virus infection, as IRGM is tar-
geted by a large number of RNA viruses and the forma-
tion of autophagosomes during infection with measles, 
hepatitis C and human immunodeficiency virus-1 is crit-
ically dependent on IRGM  [48] . Further evidence for a 
pathogenetic role for ATG16L1 in the development of 
colitis comes from a study using mice lacking the con-
served coiled-coil domain of ATG16L1. Such functional 
deficiency of ATG16L1 results in increased activation of 
the inflammasome in response to lipopolysaccharide 
causing increased secretion of IL-1  and IL-18. These 
mice are also more susceptible to DSS-induced colitis 
 [19] .
 Summary 
 A number of studies clearly provide evidence for the 
involvement of genetic variations within autophagy genes 
in the pathogenesis of CD. Dysfunction of autophagy, 
caused by genetic variations within CD susceptibility 
Barrier defect
Environmental/
‘Invironmental’
factors
Genetic
susceptibility
Dysregulated
immune response
Intestinal
inflammation
 Fig. 2. Current hypothesis of IBD patho-
genesis. An epithelial barrier defect favors 
the penetration of commensal and patho-
genic bacteria, food antigens and toxins 
into the gut mucosa. Genetic variations, 
for example in autophagy-related genes, 
contribute to the barrier defect and cause 
a dysregulated immune response to these 
molecules. The aberrant immune response 
results in a dysbalance between proin-
flammatory and anti-inflammatory cyto-
kines finally establishing the onset of 
chronic intestinal inflammation. 
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genes has been well shown to result in defective handling 
of intracellular bacteria. In addition, while ATG16L1 is 
critical for Paneth cell function and regulating the secre-
tion of proinflammatory cytokines, IRGM has been as-
sociated with mitochondrial depolarization or fission 
and apoptosis. Dysfunction of ATG16L1 and IRGM in 
vivo has been clearly associated with increased suscepti-
bility to bacterial infection and the onset of colitis ( fig. 2 ). 
All of these effects can be observed during human CD. 
These observations demonstrate a crucial role for au-
tophagy in maintaining cellular homeostasis and strong-
ly suggest that dysfunction of autophagy contributes es-
sentially to the onset of chronic intestinal inflammation 
in humans.
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